POCI

PRECISION OPTICS CORPORATION, INC.

Nasdaq · Electromedical & Electrotherapeutic Apparatus · Inc. MA · CIK 0000867840
$5.89 +2.08% $64.5M
Insider Buying Cluster (3 insiders)High Impact Filing (7/10)
Vol
Market Cap$64.5M
Cap SizeMicro Cap
Inst. Holders6 funds
Inst. Value$2.2M
Inst. Activity1 buys / 0 sells
Insider Activity3B / 0S
Insider Net $$230.0K
SEC Reports3
Press Releases2
Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. MA·CIK 0000867840·Prev Close $5.77

Recent Activity

Jun 9, 2026 other
Precision Optics to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
<p align="justify">LITTLETON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporatio
Jun 9, 2026 Event
Morphine Sulfate
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF MORPHINE SULFATE ORAL SOLUTION Risk of Medic
May 13, 2026 SEC
Precision Optics reports record Q3 revenue of $8.7M (+108% YoY), first-quarter positive adjusted EBITDA, and raises FY20
PRESS-RELEASE — Impact 7/10
Apr 1, 2026 SEC
Three corporate insiders at Precision Optics Corporation (POCI) collectively purchased $230,000 worth of shares in open-
CLUSTER — Impact 7/10
Mar 31, 2026 Insider
COLL WAYNE M was granted 1,568 shares
Chief Financial Officer @ $3.99 ($6.2K)
Mar 30, 2026 Insider
Forkey Joseph Norman bought 1,388 shares
Chief Executive Officer @ $3.60 ($5.0K)
Mar 30, 2026 Insider
TRAUT JOSEPH bought 41,666 shares
Chief Operating Officer @ $3.60 ($150.0K)
Mar 26, 2026 SEC
Precision Optics Corporation (POCI) is conducting a public offering of common stock and pre-funded warrants to raise cap
424B5 — Impact 4/10

Price Targets

No recent covering-analyst activity on file. No current recommendation available.
$8.00
Current $5.89 Low $8.00 Median $8.00 High $8.00 1 analysts
$8.00 $8.00

Analyst Ratings

Historical distribution86% buy · 7 analysts · no recent coverage
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.06 $-0.06 — $-0.06 1
Next Q $-0.07 $-0.07 — $-0.07 1
Current FY $-0.49 $-0.49 — $-0.49 1
Next FY $-0.07 $-0.07 — $-0.07 86% YoY 1

Top Institutional Holders

FundValueMove
VANGUARD CAPITAL MANAGEMENT LLC$852.2K
MORGAN STANLEY$631.3KADD
HighTower Advisors, LLC$423.9K
VANGUARD FIDUCIARY TRUST CO$128.8K
CITADEL ADVISORS LLC$102.0K

Recent Insider Trades

DateInsiderTypeValue
Mar 31, 2026COLL WAYNEA$6.2K
Mar 30, 2026Forkey JosephBUY$5.0K
Mar 30, 2026TRAUT JOSEPHBUY$150.0K
Mar 30, 2026COLL WAYNEBUY$75.0K
Mar 12, 2026Miclot AndrewF$28.8K
6 institutional holders with $2.2M total value (503,165 shares) as of 2026-Q1. Top holders: VANGUARD, MORGAN, HighTower. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1VANGUARD CAPITAL MANAGEMENT LLC194,125$852.2K38.6%
2MORGAN STANLEY143,794$631.3K28.6%ADD +56.3%
3HighTower Advisors, LLC96,565$423.9K19.2%
4VANGUARD FIDUCIARY TRUST CO29,341$128.8K5.8%
5CITADEL ADVISORS LLC23,235$102.0K4.6%
6BlackRock, Inc.16,105$70.7K3.2%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MORGAN STANLEYADD91,993143,794+56.3%$631.3K2026-Q1
BANK OF AMERICA CORP /DE/NEAR_EXIT585-91.4%$22.002025-Q3
VANGUARD GROUP INCDOUBLED59,450221,866+273.2%$1.1M2025-Q2
UBS Group AGDOUBLED1,62639,851+2350.9%$195.3K2025-Q2
UBS Group AGDOUBLED11,626+162500.0%$6.7K2025-Q1
MORGAN STANLEYTRIM65,82936,719-44.2%$177.0K2024-Q4
4 unique insiders with 6 transactions. Net insider value: $230.0K ($230.0K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Mar 31, 2026COLL WAYNE MChief Financial OfficerAWARD1,568$3.99$6.2K
Mar 30, 2026Forkey Joseph NormanChief Executive OfficerBUY1,388$3.60$5.0K
Mar 30, 2026TRAUT JOSEPHChief Operating OfficerBUY41,666$3.60$150.0K
Mar 30, 2026COLL WAYNE MChief Financial OfficerBUY20,833$3.60$75.0K
Mar 12, 2026Miclot Andrew J.DirectorTAX W/H6,372$4.52$28.8K
Mar 12, 2026Miclot Andrew J.DirectorEXERCISE20,000$1.44$28.8K
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

No recent covering-analyst activity on file. No current recommendation available.
$8.00 mean target
$8.00 Low $8.00 High
MetricValue
Current Price$5.89
Target Low$8.00
Target Mean$8.00
Target Median$8.00
Target High$8.00
# Analysts1
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.06 $-0.06 $-0.06 $0.0B 1
Next Q
2026-09-30
$-0.07 $-0.07 $-0.07 $0.0B 1
Current FY
2026-06-30
$-0.49 $-0.49 $-0.49 $0.0B 1
Next FY
2027-06-30
$-0.07 $-0.07 $-0.07 85.7% $0.0B 15.2% 1

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.060
7d ago$0.000-0.060
30d ago$0.000-0.060
60d ago$0.000-0.060
90d ago$0.000-0.060

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 9, 2026
other
Precision Optics to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
<p align="justify">LITTLETON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading
Jun 9, 2026
FDA
Morphine Sulfate
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF MORPHINE SULFATE ORAL SOLUTION Risk of Medication Errors Ensure accuracy when prescribing, dis
May 18, 2026
routine
Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
<p align="justify">LITTLETON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading d
May 14, 2026
earnings_calendar
POCI Q3 2026 Earnings Scheduled — 2026-05-14
May 13, 2026
earnings
Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET <pre>Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET</pre>
May 13, 2026
earnings_calendar
POCI Q3 2026 Earnings Scheduled — 2026-05-13
May 6, 2026
earnings
Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026
<p align="justify">LITTLETON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading d
Mar 27, 2026
offering
Precision Optics Corporation, Inc. Announces Pricing of Upsized $10 Million Public Offering of Common Stock
<p align="justify">GARDNER, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manu
Mar 26, 2026
offering
Precision Optics Corporation, Inc. Announces Proposed Public Offering of Common Stock
<p align="justify">GARDNER, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manu